Cholesterol's inhibition effect on entering of chlorzoxazone into phosphatidylethanolamine bilayer: Relevance to cytochrome P450 drug metabolism at endoplasmic reticulum membranes.
Autor: | Kano S; Division of Pure and Applied Science, Graduate School of Science and Technology, Gunma University, Maebashi, Gunma 371-8510, Japan., Takahashi H; Division of Pure and Applied Science, Graduate School of Science and Technology, Gunma University, Maebashi, Gunma 371-8510, Japan. Electronic address: hirotakahahsi@gunma-u.ac.jp. |
---|---|
Jazyk: | angličtina |
Zdroj: | Biochimica et biophysica acta. Biomembranes [Biochim Biophys Acta Biomembr] 2022 Sep 01; Vol. 1864 (9), pp. 183954. Date of Electronic Publication: 2022 May 04. |
DOI: | 10.1016/j.bbamem.2022.183954 |
Abstrakt: | Many drugs are metabolized by cytochrome P450 (CYP) in the endoplasmic reticulum (ER) membrane. Recent studies have shown that CYP-substrate drugs reach the CYP active site after entering the lipid hydrophobic part of the ER membrane. To clarify the role of cholesterol (Chol) in the CYP-related drug metabolic process, we investigated the lipid bilayer entry of CYP-substrate drugs using a model membrane system as follows. The model membrane system comprised palmitoyl-oleoyl-phosphatidylethanolamine (POPE) and Chol. Phosphatidylethanolamine is the second major phospholipid component of ER membranes. Chlorzoxazone (CZX) was used as the CYP-substrate drug. Calorimetric measurements showed that the addition of CZX to POPE bilayers decreased the gel-liquid crystal phase transition temperature; X-ray diffraction indicated that CZX distributes into the liquid crystal phase bilayers but not practically the gel phase POPE bilayers. In the presence of Chol, dialysis and X-ray structural analyses showed that Chol inhibited CZX entry into the bilayer with an increase in Chol concentration. The Chol concentration in the ER membrane (5-10 mol%) is much lower than that in the plasma membrane (approximately 30 mol%). This fact may allow CYP-substrate drugs to enter the hydrophobic portion of the ER membrane more easily than other organelle membranes, yielding efficient drug metabolism. (Copyright © 2022. Published by Elsevier B.V.) |
Databáze: | MEDLINE |
Externí odkaz: |